The state of Florida has administrered more than 10,000 doses of the monoclonal antibodies treatment at state-sponsored sites since since Florida began rolling out the program two weeks ago, the office of Gov. Ron DeSantis told The Epoch Times.
Demand for the treatment is high and is expected to go higher as word gets out and new sites are continuing to open throughout the state, Christina Pushaw, the governor's press secretary, said.
The 10,000 doses administered at state-sponsored sites do not include treatment administrered at infusion centers at clinics and hospitals around the state.
This week DeSantis is opening more treatment sites, inckuding one at The Villages, a retirement community in central Florida.
The monoclonal antibodies can prevent hospitalization or death in high-risk patients with COVID-19 and is widely available in Florida.
Gov. Greg Abbott set up sites around the state beginning November 2020 and used Bamlanivimab, the Eli Lilly & Company monoclonal antibody therapy.
When former President Donald Trump made a full recovery from COVID-19 after using monoclonals, he instructed the federal government to buy hundreds of thousands of doses of the two monoclonal treatment drugs and allocate supplies to the states, which would in turn determine distribution to hospitals and healthcare facilities.
It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.
Elections have consequences, so it is important that voters who want to save our democracy, should v
Friday, August 27, 2021
Florida Surpasses 10,000 Monoclonal Antibody Treatments at State-Sponsored Sites
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment